Lincecum et al. (2010) demonstrated the activation in ALS pathogenesis of a co-stimulatory pathway bridging the activation of T-cell responses and the amplification of the innate immune response, based on gene expression profiles obtained from whole blood of the G93A SOD1 mouse model and ALS patients [14]. Here, SOD1 is linked to amyotrophic lateral sclerosis.